SPID ® -Technology utilizes compartmentalization to enable sequential release of carbidopa and levodopa, offering a potential new approach for drug delivery in Parkinson’s disease treatment. NEW YORK--( BUSINESS WIRE )--Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced the publication of a new study in the Journal Pharmaceutics (MDPI) that highlights the effectiveness of its propriet

SPID®-Technology is a patented 3D printing technology that has the ability to manufacture and optimize complex drug delivery systems.